Thrombolytic Therapy in the Acute Period of Aortic Thromboembolism in Cats
Veterinary Evidence · 06.06.2019 · 4 (2)
DOI: 10.18849/ve.v4i2.212 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Evidence, online erschienen am 06.06.2019. Verfasst von Joshua Billy Hannabuss. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
PICO question
Of cats that present with aortic thromboembolism, do patients that receive thrombolytic therapy in the acute phase have improved survival as compared to those who do not?
Clinical bottom line
Based on the current available evidence, the use of thrombolytic therapy in the acute phase of aortic thromboembolism (ATE) does not appear to improve survival when compared to conventional supportive therapy. Frequently reported adverse side effects further questions its merits, and large scale controlled clinical trials would be required to further evaluate any benefit in the use of this therapy.
Zitieren
APA
Hannabuss, J. B. (2019). Thrombolytic Therapy in the Acute Period of Aortic Thromboembolism in Cats. Veterinary Evidence, 4(2). https://doi.org/10.18849/ve.v4i2.212
Vancouver
Hannabuss JB. Thrombolytic Therapy in the Acute Period of Aortic Thromboembolism in Cats. Veterinary Evidence. 2019;4(2). doi:10.18849/ve.v4i2.212
BibTeX
@article{Hannabuss2019,
author = {Hannabuss, Joshua Billy},
title = {Thrombolytic Therapy in the Acute Period of Aortic Thromboembolism in Cats},
journal = {Veterinary Evidence},
year = {2019},
volume = {4},
number = {2},
doi = {10.18849/ve.v4i2.212}
}
EUVIMED